About the Conference


The development of prenatal diagnosis technology has opened new experiences for families and their healthcare providers. While new technologies within medicine are always to be encouraged, they bring about new challenges and concerns as well as hopes and optimism.

Expectant parents now receive more information about their unborn child than in past years. When that news includes congenital anomalies, complex cardiac defects or chromosomal anomalies that will shorten the babies life, the journey to parenthood can take an unexpected turn.

How clinicians and other healthcare providers tell a family that their baby has a life limiting condition which means it may not live for very long can have a lasting impact. Parents in this situation can be extremely distressed, worried and vulnerable and have needs that will be different to those expecting a healthy baby.

This can also be a difficult time for hospital staff who may not have encountered such a situation before, and may feel ill equipped to provide optimal care to the woman and her family. While staff will always try and do their best for parents in these circumstances, every patient deserves to have their care on par with best international standards.

Women who receive a life-limiting prognosis for their baby deserve to have the best care possible for them and their baby during and after pregnancy. The Conference on Perinatal and Hospice care will discuss some of the issues surrounding this unique and delicate clinical presentation.




As medical technology advances, the area of perineonatology has never been so exciting. From babies being born and thriving at younger and younger gestations, to new and revolutionary developments for treating conditions that were previously thought to be invariably fatal, this sub-speciality is opening a whole new world of possibilities.

The Perinatal Conference 2016 in Dublin will examine conditions that are as exciting as they are serious.

Presentations on revolutionary treatments that could potentially influence how we manage life threatening conditions such as Bilateral Renal Agenesis, and on advances in fetal cardiac surgety that are changing the outlook for babies with Hypoplastic Left Heart Syndrome, will be sure to expand your knowledge on the care of babies who have been diagnosed with such conditions.




Anyone who is involved in the care and treatment of pregnant women, or the newborn child, would benefit from attneding this conference. In particular, those clinicians and support staff who care for families faced with the devastating diagnosis of a life limiting condition for their baby will be hugely rewarded. Healthcare provdiers who work in such specialised areas as palliative care, fetal cardiology or high risk obstetrics will aslo gain invaluable insights into these ever expanding fields of medicine.






PurplePointsB        PurplePoints_7B